Follow
Lorenzo Zammarchi
Lorenzo Zammarchi
Verified email at unifi.it
Title
Cited by
Cited by
Year
Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial
C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ...
JAMA internal medicine 181 (1), 24-31, 2021
7332021
Clinical aspects of uncomplicated and severe malaria
A Bartoloni, L Zammarchi
Mediterranean journal of hematology and infectious diseases 4 (1), 2012
5132012
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
A Mazzoni, L Salvati, L Maggi, M Capone, A Vanni, M Spinicci, ...
The Journal of clinical investigation 130 (9), 4694-4703, 2020
5042020
Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications
L Zammarchi, G Stella, A Mantella, D Bartolozzi, D Tappe, S Günther, ...
Journal of Clinical Virology 63, 32-35, 2015
2802015
An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014
G Venturi, L Zammarchi, C Fortuna, ME Remoli, E Benedetti, C Fiorentini, ...
Eurosurveillance 21 (8), 30148, 2016
2742016
Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase
D Tappe, JV Pérez-Girón, L Zammarchi, J Rissland, DF Ferreira, ...
Medical microbiology and immunology 205, 269-273, 2016
2202016
Zika virus infection in a traveller returning to Europe from Brazil, March 2015
L Zammarchi, D Tappe, C Fortuna, ME Remoli, S Günther, G Venturi, ...
Eurosurveillance 20 (23), 21153, 2015
1962015
Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis
E Bruno, A Bartoloni, L Zammarchi, M Strohmeyer, F Bartalesi, JA Bustos, ...
PLoS neglected tropical diseases 7 (10), e2480, 2013
1572013
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority …
D Buonfrate, J Salas-Coronas, J Muñoz, BT Maruri, P Rodari, F Castelli, ...
The Lancet infectious diseases 19 (11), 1181-1190, 2019
1562019
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990–2011
L Zammarchi, M Strohmeyer, F Bartalesi, E Bruno, J Muñoz, D Buonfrate, ...
PloS one 8 (7), e69537, 2013
1382013
Epidemiology and management of cysticercosis and Taenia solium taeniasis in Europe, systematic review 1990–2011
L Zammarchi, M Strohmeyer, F Bartalesi, E Bruno, J Muñoz, D Buonfrate, ...
PloS one 8 (7), e69537, 2013
1382013
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19
A Mazzoni, N Di Lauria, L Maggi, L Salvati, A Vanni, M Capone, ...
The Journal of clinical investigation 131 (12), 2021
1262021
Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries
A Requena-Méndez, D Buonfrate, J Gomez-Junyent, L Zammarchi, ...
The American journal of tropical medicine and hygiene 97 (3), 645, 2017
1172017
Schistosomiasis in European travelers and migrants: analysis of 14 years TropNet surveillance data
T Lingscheid, F Kurth, J Clerinx, S Marocco, B Trevino, M Schunk, ...
The American journal of tropical medicine and hygiene 97 (2), 567, 2017
952017
Accuracy of parasitological and immunological tests for the screening of human schistosomiasis in immigrants and refugees from African countries: An approach with Latent Class …
A Beltrame, M Guerriero, A Angheben, F Gobbi, A Requena-Mendez, ...
PLoS Neglected Tropical Diseases 11 (6), e0005593, 2017
922017
RCT-TCZ-COVID-19 Study Group. Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial
C Salvarani, G Dolci, M Massari, DF Merlo, S Cavuto, L Savoldi, P Bruzzi, ...
JAMA Intern Med 181 (1), 24-31, 2021
912021
A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries
L Zammarchi, G Casadei, M Strohmeyer, F Bartalesi, C Liendo, A Matteelli, ...
BMC health services research 15, 1-11, 2015
852015
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
AM Vannucchi, B Sordi, A Morettini, C Nozzoli, L Poggesi, F Pieralli, ...
Leukemia 35 (4), 1121-1133, 2021
752021
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients
A Mazzoni, L Maggi, M Capone, M Spinicci, L Salvati, MG Colao, A Vanni, ...
European Journal of Immunology 50 (12), 2013-2024, 2020
682020
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020
F Lagi, M Piccica, L Graziani, I Vellere, A Botta, M Tilli, L Ottino, B Borchi, ...
Eurosurveillance 25 (17), 2000556, 2020
662020
The system can't perform the operation now. Try again later.
Articles 1–20